Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
141 USD | +1.16% | -2.24% | +23.31% |
May. 31 | Goldman Sachs Adjusts Price Target on Xylem to $159 From $155 | MT |
May. 31 | Oppenheimer Adjusts Price Target on Xylem to $152 From $147 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 41.4 times its estimated earnings per share for the ongoing year.
- With an enterprise value anticipated at 4.07 times the sales for the current fiscal year, the company turns out to be overvalued.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Industrial Machinery & Equipment
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+23.31% | 34.19B | A | ||
+15.70% | 88.8B | A- | ||
+15.37% | 68.32B | B | ||
+20.31% | 37.54B | B- | ||
+5.69% | 27.45B | B+ | ||
+6.08% | 26.46B | B- | ||
+1.10% | 26.21B | C+ | ||
+19.51% | 25.26B | B | ||
+2.85% | 22.44B | B+ | ||
+20.28% | 19.04B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- XYL Stock
- Ratings Xylem Inc.